Skip Navigation


Annals of Oncology Advance Access originally published online on March 5, 2008
Annals of Oncology 2008 19(6):1187-1194; doi:10.1093/annonc/mdn025
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
19/6/1187    most recent
mdn025v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in Ann Oncol
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Héry, C.
Right arrow Articles by Autier, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Héry, C.
Right arrow Articles by Autier, P.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2008. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oxfordjournals.org

epidemiology

Quantification of changes in breast cancer incidence and mortality since 1990 in 35 countries with Caucasian-majority populations

C. Héry, J. Ferlay, M. Boniol and P. Autier*

Data Analysis and Interpretation Group, Epidemiology Methods and Support Group, International Agency for Research on Cancer, Lyon, France

* Correspondence to: Dr P. Autier, International Agency for Research on Cancer, 150 Cours Albert Thomas, F-69372 Lyon Cedex 08, France. Tel: +33-472-73-81-63; Fax: +33-472-73-83-51; E-mail: autierp{at}iarc.fr

Background: Since 1985 considerable changes have taken place in the early detection and treatment of breast cancer. We quantified breast cancer trends for 35 countries with populations mainly of European ancestry.

Methods: Incidence data were extracted from cancer registries and mortality data from World Health Organization database. Overall percentage change from 1990 to 2002 was quantified for all ages and for three different age-groups (35–49, 50–69 and ≥70 years of age).

Results: The incidence percent change in women of all ages varied from 2.1% in Canada to 54.2% in Lithuania. Main increases in incidence were observed for women 50–69 years old, from 12.4% in Canada until 105.3% in Norway. Decreases in mortality of >20% were observed in nine countries. Mortality decreases were highest in women 35–49 years old and lowest in women ≥70 years. The magnitude of mortality decrease from 1990 to 2002 was not related to the mortality rate observed in 1990.

Conclusions: While increases in breast cancer incidence mainly concerned women ≥50 years, decreases in mortality were more marked in women 35–49 years old. Large disparities in changes in mortality rates probably reflect differences in detection of and management of breast cancer.

Key words: breast cancer, epidemiology, temporal trends

Received for publication October 31, 2007. Accepted for publication January 11, 2008.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related articles in Ann Oncol:

In this issue

Ann Oncol 2008 19: 1031. [Extract] [FREE Full Text]  



This article has been cited by other articles:


Home page
 JNCI J Natl Cancer InstHome page
M. Pollan, R. Pastor-Barriuso, E. Ardanaz, M. Arguelles, C. Martos, J. Galceran, M.-J. Sanchez-Perez, M.-D. Chirlaque, N. Larranaga, R. Martinez-Cobo, et al.
Recent Changes in Breast Cancer Incidence in Spain, 1980-2004
J Natl Cancer Inst, October 26, 2009; (2009) djp358v1.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
T. Deng, J. C. Liu, K. I. Pritchard, A. Eisen, and E. Zacksenhaus
Preferential Killing of Breast Tumor Initiating Cells by N,N-Diethyl-2-[4-(Phenylmethyl)Phenoxy]Ethanamine/Tesmilifene
Clin. Cancer Res., January 1, 2009; 15(1): 119 - 130.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.